Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

Lincoln Minerals has begun a detailed assay program targeting base metal intervals in unassayed drill cores at the Minbrie Project.

Over the course of their lives, humans and other animals typically learn to avoid situations and stimuli that are dangerous ...

We have written at length about the U.S. Food and Drug Administration’s (FDA’s) actions to promulgate regulations specifying the agency’s authority ...

Lincoln Minerals is re-assaying historic core aiming to uncover new base metal potential in South Australia after it was only ...

Schematic representation of the assay. (Photo credit: Justo et al., 2024) Using the knowledge gained in the sandwich ELAA ...

Wallbridge Mining Company Limited (TSX: WM, OTCQB: WLBMF) (“Wallbridge” or the “Company”) is pleased to announce that it has received final assay results ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

High-grade assay results from drilling near two past producing mines on LAURION Mineral Exploration’s (TSXV: LME; US-OTC: ...